Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
Authors
Keywords
Stage II/III colorectal cancer, LncRNA, Machine learning, Recurrence, Chemotherapy
Journal
EBioMedicine
Volume 75, Issue -, Pages 103750
Publisher
Elsevier BV
Online
2021-12-15
DOI
10.1016/j.ebiom.2021.103750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The clinical relevance of gene expression based prognostic signatures in colorectal cancer
- (2021) Pankaj Ahluwalia et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer
- (2021) Zaoqu Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prognostic Cancer Gene Expression Signatures: Current Status and Challenges
- (2021) Yuquan Qian et al. Cells
- Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response
- (2020) Lin Huan et al. Molecular Cancer
- Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
- (2020) Yongsheng Li et al. Nature Communications
- Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
- (2020) Koncina et al. Cancers
- Potential Therapeutic Targets of B7 Family in Colorectal Cancer
- (2020) Changgang Wang et al. Frontiers in Immunology
- Characterization of lncRNA-Perturbed TLR-Signaling Network Identifies Novel lncRNA Prognostic Biomarkers in Colorectal Cancer
- (2020) Yanjie Chu et al. Frontiers in Cell and Developmental Biology
- Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer
- (2019) Takatoshi Matsuyama et al. Molecular Cancer
- CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
- (2019) J. L. Hu et al. Molecular Cancer
- Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
- (2019) R Dienstmann et al. ANNALS OF ONCOLOGY
- AJCC 8th Edition: Colorectal Cancer
- (2018) Martin R. Weiser ANNALS OF SURGICAL ONCOLOGY
- Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis
- (2018) Taewan Kim et al. CANCER LETTERS
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
- (2018) Chunru Lin et al. TRENDS IN CELL BIOLOGY
- Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
- (2018) Ziwen Zhu et al. OncoTargets and Therapy
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
- (2017) Claudio Isella et al. Nature Communications
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- From tumour heterogeneity to advances in precision treatment of colorectal cancer
- (2016) Cornelis J. A. Punt et al. Nature Reviews Clinical Oncology
- Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
- (2016) Zsófia Sztupinszki et al. Scientific Reports
- ColoFinder: a prognostic 9-genes signature improve prognosis for 871 stage II and III colorectal cancer patients
- (2016) Mingguang Shi et al. PeerJ
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Chemotherapy for Stage II Colon Cancer
- (2015) Anna Varghese Clinics in Colon and Rectal Surgery
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
- (2011) Robin K. Kelley et al. Clinical Colorectal Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started